BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 17636808)

  • 21. Cotrimoxazole prophylaxis for opportunistic infections in children with HIV infection.
    Grimwade K; Swingler GH
    Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD003508. PubMed ID: 16437457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pneumocystis jirovecii pneumonia in kidney transplantation.
    Goto N; Oka S
    Transpl Infect Dis; 2011 Dec; 13(6):551-8. PubMed ID: 22093172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pneumocystis carinii severe pneumonia among human immunodeficiency virus-infected children in Thailand: the effect of a primary prophylaxis strategy.
    Chokephaibulkit K; Wanachiwanawin D; Chearskul S; Wanprapa N; Unganont K; Tantinikorn W; Udompunthurak S
    Pediatr Infect Dis J; 1999 Feb; 18(2):147-52. PubMed ID: 10048687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preventive effect of sulfamethoxasole-trimethoprim on Pneumocystis jiroveci pneumonia in patients with interstitial pneumonia.
    Enomoto T; Azuma A; Matsumoto A; Nei T; Fujita K; Hattori K; Saito Y; Abe S; Usuki J; Kudoh S
    Intern Med; 2008; 47(1):15-20. PubMed ID: 18175999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotic prophylaxis for preventing burn wound infection.
    Barajas-Nava LA; López-Alcalde J; Roqué i Figuls M; Solà I; Bonfill Cosp X
    Cochrane Database Syst Rev; 2013 Jun; (6):CD008738. PubMed ID: 23740764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prophylaxis for Pneumocystis pneumonia in patients with rheumatoid arthritis treated with biologics, based on risk factors found in a retrospective study.
    Katsuyama T; Saito K; Kubo S; Nawata M; Tanaka Y
    Arthritis Res Ther; 2014 Feb; 16(1):R43. PubMed ID: 24495443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of Pneumocystis carinii pneumonia in patients with AIDS.
    Wordell CJ; Hauptman SP
    Clin Pharm; 1988 Jul; 7(7):514-27. PubMed ID: 3138063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology and risk factors associated with Pneumocystis jirovecii pneumonia in kidney transplant recipients after 6-month trimethoprim-sulfamethoxazole prophylaxis: A case-control study.
    Park SY; Jung JH; Kwon H; Shin S; Kim YH; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH; Han DJ
    Transpl Infect Dis; 2020 Apr; 22(2):e13245. PubMed ID: 31943590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cotrimoxazole for prophylaxis or treatment of opportunistic infections of HIV/AIDS in patients with previous history of hypersensitivity to cotrimoxazole.
    Lin D; Li WK; Rieder MJ
    Cochrane Database Syst Rev; 2007 Apr; (2):CD005646. PubMed ID: 17443608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV-infection.
    Briel M; Bucher HC; Boscacci R; Furrer H
    Cochrane Database Syst Rev; 2006 Jul; (3):CD006150. PubMed ID: 16856118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
    Chaisson RE; Keruly J; Richman DD; Moore RD
    Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pneumocystis pneumonia in children receiving chemotherapy.
    Prasad P; Nania JJ; Shankar SM
    Pediatr Blood Cancer; 2008 Apr; 50(4):896-8. PubMed ID: 17458875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The efficacy and safety of reduced-dose sulfamethoxazole-trimethoprim for chemoprophylaxis of
    Harada T; Kato R; Sueda Y; Funaki Y; Takata M; Okazaki R; Hasegawa Y; Yamasaki A
    Mod Rheumatol; 2021 May; 31(3):629-635. PubMed ID: 32820678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized trial of daily and thrice-weekly trimethoprim-sulfamethoxazole for the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected persons. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA).
    El-Sadr WM; Luskin-Hawk R; Yurik TM; Walker J; Abrams D; John SL; Sherer R; Crane L; Labriola A; Caras S; Pulling C; Hafner R
    Clin Infect Dis; 1999 Oct; 29(4):775-83. PubMed ID: 10589887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety of dapsone as Pneumocystis carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with allergy to trimethoprim/sulfamethoxazole.
    Beumont MG; Graziani A; Ubel PA; MacGregor RR
    Am J Med; 1996 Jun; 100(6):611-6. PubMed ID: 8678080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimal regimens of sulfamethoxazole-trimethoprim for chemoprophylaxis of Pneumocystis pneumonia in patients with systemic rheumatic diseases: results from a non-blinded, randomized controlled trial.
    Utsunomiya M; Dobashi H; Odani T; Saito K; Yokogawa N; Nagasaka K; Takenaka K; Soejima M; Sugihara T; Hagiyama H; Hirata S; Matsui K; Nonomura Y; Kondo M; Suzuki F; Tomita M; Kihara M; Yokoyama W; Hirano F; Yamazaki H; Sakai R; Nanki T; Koike R; Kohsaka H; Miyasaka N; Harigai M
    Arthritis Res Ther; 2017 Jan; 19(1):7. PubMed ID: 28100282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A dose-escalation regimen of trimethoprim-sulfamethoxazole is tolerable for prophylaxis against Pneumocystis jiroveci pneumonia in rheumatic diseases.
    Takenaka K; Komiya Y; Ota M; Yamazaki H; Nagasaka K
    Mod Rheumatol; 2013 Jul; 23(4):752-8. PubMed ID: 22907597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tolerability of low-dose sulfamethoxazole/trimethoprim for Pneumocystis jirovecii pneumonia prophylaxis in kidney transplant recipients.
    Zmarlicka M; Martin ST; Cardwell SM; Nailor MD
    Prog Transplant; 2015 Sep; 25(3):210-6. PubMed ID: 26308779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validating literature-based models with direct clinical trial results: the cost-effectiveness of secondary prophylaxis for PCP in AIDS patients.
    Freedberg KA; Hardy WD; Holzman RS; Tosteson AN; Craven DE
    Med Decis Making; 1996; 16(1):29-35. PubMed ID: 8717596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The tolerance for zidovudine plus thrice weekly or daily trimethoprim-sulfamethoxazole with and without leucovorin for primary prophylaxis in advanced HIV disease. California Collaborative Treatment Group.
    Bozzette SA; Forthal D; Sattler FR; Kemper C; Richman DD; Tilles JG; Leedom J; McCutchan JA
    Am J Med; 1995 Feb; 98(2):177-82. PubMed ID: 7847434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.